Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 DDI Study of Ensitrelvir With Itraconazole or Carbamazepine in Healthy Adults
jRCT2071230049Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ensitrelvir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Ensitrelvir Cmax, Ensitrelvir Tmax and 13 more. Started Aug 2023; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2071230049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230049.